Haemonetics Publishes Inaugural Corporate Responsibility Report
Haemonetics' 2022 Corporate Responsibility report provides data for its fiscal year 2022 that ended on
- Updates on the company's human capital initiatives designed to attract and retain top talent and foster a diverse and inclusive workforce, including certain workforce diversity data and a link to Haemonetics' latest EEO-1 report.
- Reporting on the company's environmental initiatives, including the results from Haemonetics' first Scope 1 and 2 greenhouse gas emissions assessment, completed in calendar 2022.
- Additional information on the company's programs and practices relating to, among other topics, corporate governance; ethics and compliance; occupational health and safety; technology and innovation; product quality and safety; and cybersecurity.
"As we continue to grow our business, we are guided by our Purpose and mindful of the expectations of our stakeholders whose trust we value," said
Haemonetics' 2022 Corporate Responsibility Report is available on the company's website here.
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-publishes-inaugural-corporate-responsibility-report-301802894.html